Viemed Healthcare Inc 's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Viemed Healthcare Inc 's ROA in the third quarter of 2026?
Viemed Healthcare Inc achieved a return on average assets (ROA) of 7.95 % in its third quarter of 2026, which is below Viemed Healthcare Inc 's average return on assets, which stands at 10.86%.

ROA has improved compared to 7.51% in the second quarter of 2026, due to net income growth.

However, within the Healthcare sector 122 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2026 quarter, so far to 789, from total ROA ranking in the second quarter of 2026 at 889.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Total Assets Change	4.18 %	10.63 %	10.83 %	15.79 %	21.56 %
Y / Y Net Income Change	28.83 %	-10.77 %	0.11 %	31.46 %	-7.81 %
Net Income (TTM) in million	16	15	15	15	14
Return On Assets (TTM)	7.95 %	7.51 %	7.88 %	8.08 %	7.62 %
VMD's Total Ranking	# 789	# 889	# 836	# 791	# 869
Total Assets (TTM) in million	208	204	197	199	199
Seq. Total Assets Change	1.67 %	3.48 %	-0.9 %	-0.08 %	7.97 %
Seq. Net Income Change	59.93 %	6.89 %	-53.35 %	61.56 %	10.77 %

VMD's 5 Years Annual ROA >> Back to VMD Management Effectiveness >> Compare VMD ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 14
Sector	# 123
Overall	# 833

Return On Assets Statistics
High	Average	Low
32.1 %	10.86 %	5.01 %
(Jun 30 2020)		(Mar 31 2023)

Financial Statements
Viemed Healthcare Inc 's Assets	$ 208 million	VMD's Balance sheet
Viemed Healthcare Inc 's Income	$ 5 million	Quarterly VMD's Income Statement
VMD's Income by Division		See VMD's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	15.79 %	12.95 %	32.71 %	1.26 %	7.95 %
Total Assets in million	199	172	152	115	113
Y / Y Net Income Change	34.77 %	11.38 %	64.63 %	-31.82 %	-71.06 %
Net Income in million	15	11	10	6	9
Annual Return On Assets	7.72 %	6.63 %	6.73 %	5.42 %	8.05 %

VMD's 5 Years Annual ROA >> Back to VMD Management Effectiveness >> Compare VMD ROA to its Competitors

Comment on VMD's ROA in the fiscal year ending 2025

In the fiscal year 2025 ROA improved to 7.72 % compared to prior year, due to annual net income growth of 34.77 % to $15.38 million, while value of Viemed Healthcare Inc 's overall assets grew just by 15.79 % to $199.15 million, compared to $199.15 a year before.

More Return On Assets Ratios
VMD's' Return on Assets at Yahoo Finance
Healthcare Facilities Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
VMD's Roa Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for VMD's Competitors
Subscribers only: Roa for Viemed Healthcare Inc 's Suppliers
Subscribers only: Return On Assets for VMD's Customers

You may also want to know
VMD's Roi	VMD's Inventory Turnover Ratio	VMD's Growth Rates	VMD's Dividend Comparisons
	VMD's Profitability Ratios	VMD's Asset Turnover Ratio	VMD's Dividend Growth
VMD's Roe	VMD's Valuation Ratios	VMD's Financial Strength Ratios	VMD's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector	ROA
Acadia Pharmaceuticals Inc	21.60 %
Standard Biotools Inc	21.56 %
Eli Lilly And Company	21.24 %
Iradimed Corporation	20.89 %
Resmed Inc	18.67 %
Alector Inc	18.37 %
Corcept Therapeutics Inc	18.09 %
Chemed Corporation	17.73 %
Halozyme Therapeutics Inc	17.26 %
Pro dex Inc	16.75 %
Denali Therapeutics Inc	16.42 %
Krystal Biotech Inc	15.48 %
West Pharmaceutical Services Inc	15.47 %
Dexcom Inc	15.47 %
Intuitive Surgical Inc	14.71 %
Vertex Pharmaceuticals Inc	14.16 %
Neurocrine Biosciences Inc	13.69 %
Illumina Inc	13.43 %
Healthcare Services Group Inc	12.79 %
Kiniksa Pharmaceuticals International Plc	12.64 %
Tenet Healthcare Corp	12.39 %
Hca Healthcare Inc	11.73 %
Carlisle Companies Incorporated	11.72 %
Regeneron Pharmaceuticals Inc	11.50 %
Lantheus Holdings Inc	11.43 %
Msa Safety Inc	11.01 %
Encompass Health Corporation	10.99 %
Inspire Medical Systems inc	10.89 %
Transmedics Group Inc	10.67 %
Bristol myers Squibb Company	10.47 %

Date modified: 2026-11-06T13:02:59+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.